FLII and Ewing sarcoma: Given that FLI-1 inhibitors have already been identified using human Ewing’s-sarcoma and erythroleukaemic cell lines, the Fli-1 mouse model developed here should be informative in elucidating pathways critical for inhibiting Fli-1-induced T cell proliferation [55], [56].